CLDX icon

Celldex Therapeutics
CLDX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$44
68% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Etzer Darout
50% 1-yr CLDX win rate
11 Nov ‘25 21 days ago
Mizuho
Mizuho
Joseph Catanzaro
0% 1-yr CLDX win rate
21 Oct ‘25 1 month ago
Canaccord Genuity
Canaccord Genuity
Edward Nash
100% 1-yr CLDX win rate
17 Sep ‘25 2 months ago